By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Inotek Pharmaceuticals Corporation 

100 Cummings Center
Suite 419E
Beverly  Massachusetts  01915  U.S.A.
Phone: 978-232-9660 Fax: 978-232-8975



Company News
Inotek (ITEK) Announces Top-Line Results Of Phase II Fixed-Dose Combination Trial Of Trabodenoson And Provides Corporate Update 7/10/2017 7:36:01 AM
Massachusetts' Inotek (ITEK) Exploring Strategic Alternatives After Another Glaucoma Trial Failure 7/10/2017 5:46:30 AM
Inotek (ITEK) Reports First Quarter 2017 Financial Results And Operational Highlights 5/10/2017 6:16:45 AM
Inotek (ITEK) Presents Preclinical Data On Trabodenoson At Association for Research in Vision & Ophthalmology 2017 Annual Meeting 5/9/2017 6:42:26 AM
Inotek (ITEK) Completes Patient Recruitment In Phase II Trial Of A Fixed-Dose Combination (FDC) Of Trabodenoson And Latanoprost 4/11/2017 6:14:33 AM
Inotek (ITEK) Reports Fiscal Year 2016 Financial Results And Operational Highlights 3/16/2017 6:18:29 AM
Inotek (ITEK) Plunges On Failed Phase III Glaucoma Trial 1/3/2017 5:31:17 AM
Inotek (ITEK) Reports Third Quarter 2016 Financial Results And Operational Highlights 11/9/2016 10:44:41 AM
Inotek (ITEK) To Present At The 2016 Ophthalmology Innovation Summit 10/7/2016 10:33:59 AM
Inotek (ITEK) Appoints Timothy Barberich To Board Of Directors 9/29/2016 12:38:46 PM